Number of global clinical trials done in UK fell by two thirds after EU directiveBMJ 2009; 338 doi: https://doi.org/10.1136/bmj.b1052 (Published 13 March 2009) Cite this as: BMJ 2009;338:b1052
- Anne Gulland
A leading clinician has warned that patients are dying because a European Union directive that was intended to streamline the process of clinical trials has had the opposite effect.
Rory Collins, professor of epidemiology and medicine at Oxford University, told a briefing organised by the Science Media Centre on the threat to clinical trials that the “hugely increased bureaucratic burden” had made it much more difficult to investigate new treatments.
“It’s killing people. I believe that’s a fact,” he said. “People are dying unnecessarily because the way in which the regulation and bureaucracy is working has prevented us getting the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial